Check the time stamp on this data. Updated AI-Generated Signals for Catalyst Pharmaceuticals Inc. (CPRX) available here: CPRX ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CPRX is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. CPRX has a Momentum Style Score of B, and shares are up 2.7% over the past ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 11.63% ...
Zacks.com on MSN19d
Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
This was the stock's second consecutive day of losses.
Truist Financial analyst Joon Lee maintained a Buy rating on Catalyst Pharma (CPRX – Research Report) today. The company’s shares closed ...
Investors in Catalyst Pharmaceuticals Inc (Symbol: CPRX) saw new options become available this week, for the January 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback